Skip to main content
. 2021 May 17;11:670490. doi: 10.3389/fonc.2021.670490

Figure 3.

Figure 3

Comparison of immunomodulatory drugs’ targets in clinical trials for metastatic colorectal cancer between two clusters. The P values are labeled using asterisks (ns, no significance, **P < 0.01, ***P < 0.001).